πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10130604

Composition and method for treating neurodegenerative disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117915

Modulation of yeast-based immunotherapy products and responses

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10111861

Treatment of breast cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10080376

Method for enhancing postprocessing content of beneficial compounds in beverages naturally

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10076520

Use of tyrosine kinase inhibitor in cancer treatment

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10052393

Multifunctional nanomaterials for the treatment of cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10046036

Chemically modified cystathionine Ξ²-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9994901

Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary dis

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9980634

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9949928

Biodegradable copolymers, systems including the copolymers, and methods of forming and usi

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9949484

Antimicrobial polyurethane materials and methods of forming and using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9950044

Treatment of pulmonary vascular remodeling with neprilysin

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9938353

Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9925162

Methods and compositions for inducing physiological hypertrophy

The Regents of the University of Colorado Β· Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9895420

IL-1beta propeptide and IL-1Ra chimera and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9885018

High efficiency reprogramming of fibroblasts into cardiomyocytes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884096

Compositions and methods related to graft versus host disease and treatments thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840520

Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetyla

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820957

Methods of treating autoimmunity

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820951

Pulmonary disease treatment and diagnosis based on Arhgef1

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9815890

Antibodies to the C3d fragment of complement component 3

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9796961

Conditionally immortalized long-term stem cells and methods of making and using such cells

The Regents of the University of Colorado Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9775876

Compositions and methods for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9759731

Disease severity index for assessment of chronic liver disease and method for diagnosis of

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted